/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR

Chronicles

The story behind the story

← → days · ↑ ↓ browse · Enter similar · o open

Amidst tariffs brawl with US, China is delaying reviews of Qualcomm's NXP deal and Bain's acquisition of Toshiba's chip unit, raising fears both deals may fail

Wall Street Journal :

Wall Street Journal

Context & Ripple Effects

In April 2018, with Washington and Beijing trading tariff threats, China's regulators went quiet on two high-stakes chip deals awaiting review: Qualcomm's purchase of NXP and Bain's takeover of Toshiba's memory unit. Both needed Beijing's sign-off as their last remaining approval, so the delay alone put closing timelines at risk.

The standoff became a template. Weeks later came reports of an imminent conditional approval over dominance concerns in areas like mobile payments, followed by conflicting sourcing — Reuters heard no approval was in hand while other outlets said otherwise (leaving the deal's status genuinely unclear). Seven years on, the same leverage reappears: rising doubt over China clearing Synopsys' $35B Ansys acquisition in the 2025 tariff fight, against a reported Beijing list of US tech targets including Broadcom and Synopsys.

First-order effects

  • Qualcomm and Bain are left with deals whose final regulatory gate is held by an adversary government — every week of silence pushes them closer to walk-away deadlines, and Toshiba's planned exit from its chip unit stalls with them.

Second-order effects

  • NXP shareholders and Toshiba's creditors face repricing risk: if Beijing's conditions harden or approval never lands, both sellers must weigh lower bids or alternative buyers rather than wait out a political process they cannot control.

Third-order effects

  • Antitrust review becomes a standing instrument of US-China tech conflict: any American semiconductor firm whose M&A requires SAMR clearance now carries a structural political risk premium, a pattern the 2025 Synopsys-Ansys uncertainty shows repeating rather than fading.

The trend: Beijing is converting merger approvals for US chip companies into a recurring trade-war lever, with each tariff escalation putting pending cross-border semiconductor deals at risk of delay or collapse.